Letters to the Editor

Comparison of EasyM, a clonotypic mass spectrometry assay, and EuroFlow minimal residual disease assessment in multiple myeloma

Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne
Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne
Alfred Pathology, The Alfred Hospital, Melbourne
Rapid Novor, Kitchener
Rapid Novor, Kitchener
Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne
Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne
Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne
Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne
Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne
Department of Haematology, Royal Hobart Hospital, Hobart
Department of Haematology, Eastern Health, Melbourne
Department of Haematology, Royal Hobart Hospital, Hobart
Department of Haematology, St. Vincent's Hospital Melbourne, Melbourne
Rapid Novor, Kitchener
Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne
Haematologica Early view Nov 7, 2024 https://doi.org/10.3324/haematol.2024.285933